Novel Nanoformulations to Overcome Obstacles in Herbal Drug Delivery for Alzheimer's Disease.

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

Nanomedicine is a rapidly growing field in pharmaceutical science, driven by the enhanced quality of nano-formulations that improve the treatment of various diseases. Nano-sized novel drug delivery techniques for herbal pharmaceuticals have the potential to enhance activity and address concerns related to medicinal plants in the future. Natural chemicals show promise in various neurodegenerative diseases, but their permeability across the blood-brain barrier prevents them from reaching the nervous system. By improving molecular monitoring, synthesis, and diagnostics, pharmaceutical nanotechnology provides improved controlled drug delivery for the treatment of neurodegeneration. The evaluated and investigated data from recent studies were gathered using Google Scholar as a search engine. We reviewed and analysed research publications from databases like Bentham Science, Elsevier, PubMed, and ScienceDirect, among others, to summarize the findings. Curcumin, Centella asiatica, thymoquinone, Hypericum perforatum, Panax ginseng, quercetin, piperine, and a variety of other herbs and herbal medicines have all been examined for their potential to aid in the treatment of brain disorders like Alzheimer's disease. To enhance drug bioavailability in the brain, nanoformulations, including phytosomes, transferosomes, ethosomes, and niosomes, have been utilized as pharmaceuticals. Herbs and herbal medicines have been synthesized into nanoparticle form to enhance tissue distribution, achieve sustained delivery, and protect against physicochemical degradation while also increasing the solubility and bioavailability of poorly soluble herbal products. To overcome physiological complications, researchers must develop lab-scale approaches, characterization methodologies, and targeting tactics for nanoformulations with high translational potential early in product development.

Similar Papers
  • Discussion
  • Cite Count Icon 45
  • 10.1016/s0002-9440(10)64777-3
The Role of NAC in Amyloidogenesis in Alzheimer's Disease
  • Feb 1, 2000
  • The American Journal of Pathology
  • Makoto Hashimoto + 12 more

The Role of NAC in Amyloidogenesis in Alzheimer's Disease

  • Research Article
  • Cite Count Icon 184
  • 10.1016/j.biopsych.2013.08.020
Psychosis in Alzheimer’s Disease
  • Oct 6, 2013
  • Biological Psychiatry
  • Patrick S Murray + 3 more

Psychosis in Alzheimer’s Disease

  • Research Article
  • Cite Count Icon 146
  • 10.1016/j.neuron.2014.01.026
Intrinsic Connectivity Identifies the Hippocampus as a Main Crossroad between Alzheimer’s and Semantic Dementia-Targeted Networks
  • Mar 1, 2014
  • Neuron
  • Renaud La Joie + 11 more

Intrinsic Connectivity Identifies the Hippocampus as a Main Crossroad between Alzheimer’s and Semantic Dementia-Targeted Networks

  • Research Article
  • Cite Count Icon 233
  • 10.1074/jbc.m110.112664
MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons
  • Jun 1, 2010
  • Journal of Biological Chemistry
  • Elisa Vilardo + 4 more

The amyloid precursor protein (APP) and its proteolytic product amyloid beta (Abeta) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3'-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and Abeta load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1beta (IL-lbeta). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of Abeta, suggesting a possible role for miR-101 in neuropathological conditions.

  • Front Matter
  • Cite Count Icon 66
  • 10.1016/j.jhep.2010.12.003
Herbal medicine hepatotoxicity: A new step with development of specific biomarkers
  • Dec 7, 2010
  • Journal of Hepatology
  • Dominique Larrey + 1 more

Herbal medicine hepatotoxicity: A new step with development of specific biomarkers

  • Research Article
  • Cite Count Icon 37
  • 10.1016/j.jphotobiol.2021.112207
Transcranial photobiomodulation in the management of brain disorders.
  • May 5, 2021
  • Journal of photochemistry and photobiology. B, Biology
  • Katayoon Montazeri + 5 more

Transcranial photobiomodulation in the management of brain disorders.

  • Research Article
  • Cite Count Icon 193
  • 10.2353/ajpath.2008.080434
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
  • Nov 1, 2008
  • The American Journal of Pathology
  • Natalia Louneva + 7 more

Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease

  • Research Article
  • Cite Count Icon 10
  • 10.4066/amj.2015.2467
Herb-drug interaction: The importance of communicating with primary care physicians.
  • Jul 31, 2015
  • The Australasian medical journal
  • Gerard Ahern

Herb-drug interaction: The importance of communicating with primary care physicians.

  • Research Article
  • Cite Count Icon 37
  • 10.1016/j.ajpath.2011.10.027
Rac1b Increases with Progressive Tau Pathology within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease
  • Dec 2, 2011
  • The American Journal of Pathology
  • Sylvia E Perez + 9 more

Rac1b Increases with Progressive Tau Pathology within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease

  • Research Article
  • Cite Count Icon 23
  • 10.2353/ajpath.2007.070015
Quantitative Proteomics Identifies Surfactant-Resistant α-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy
  • Sep 1, 2007
  • The American Journal of Pathology
  • Wan Yang + 11 more

Quantitative Proteomics Identifies Surfactant-Resistant α-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy

  • Research Article
  • Cite Count Icon 691
  • 10.1016/j.neuron.2012.03.004
Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
  • Mar 1, 2012
  • Neuron
  • Juan Zhou + 4 more

Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome

  • Research Article
  • Cite Count Icon 647
  • 10.1016/j.neuron.2009.08.039
Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?
  • Oct 1, 2009
  • Neuron
  • Kurt M Lucin + 1 more

Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?

  • Research Article
  • Cite Count Icon 137
  • 10.1074/jbc.m110.169839
Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression
  • Jan 1, 2011
  • Journal of Biological Chemistry
  • Mariko Noda + 7 more

Glutamate-induced excito-neurotoxicity likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases. Microglial clearance of dying neurons and associated debris is essential to maintain healthy neural networks in the central nervous system. In fact, the functions of microglia are regulated by various signaling molecules that are produced as neurons degenerate. Here, we show that the soluble CX3C chemokine fractalkine (sFKN), which is secreted from neurons that have been damaged by glutamate, promotes microglial phagocytosis of neuronal debris through release of milk fat globule-EGF factor 8, a mediator of apoptotic cell clearance. In addition, sFKN induces the expression of the antioxidant enzyme heme oxygenase-1 (HO-1) in microglia in the absence of neurotoxic molecule production, including NO, TNF, and glutamate. sFKN treatment of primary neuron-microglia co-cultures significantly attenuated glutamate-induced neuronal cell death. Using several specific MAPK inhibitors, we found that sFKN-induced heme oxygenase-1 expression was primarily mediated by activation of JNK and nuclear factor erythroid 2-related factor 2. These results suggest that sFKN secreted from glutamate-damaged neurons provides both phagocytotic and neuroprotective signals.

  • Research Article
  • Cite Count Icon 22
  • 10.1111/j.1440-1819.2011.02253.x
Editorial: New drugs for Alzheimer's disease in Japan
  • Aug 1, 2011
  • Psychiatry and Clinical Neurosciences
  • Masatoshi Takeda + 2 more

Editorial: New drugs for Alzheimer's disease in Japan

  • Research Article
  • Cite Count Icon 301
  • 10.1016/j.neuron.2013.01.002
Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration
  • Jan 1, 2013
  • Neuron
  • William Jagust

Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.